this sales data from November was sent to me by a friend. (image below).
clearly showing Oli6 sales are very much higher than bubs.
NUC (Oli6) is $135 million market capitalisation compared to BUB at near $580 million.
NUC forecasting $18 million revenue in 2020 but I believe they will easily exceed that number.
SAMR certification is further upside if and when approved. (lodged in March 2018)
Ben Dingle the founder and MD is impressive.
I know which baby goat formula company I would prefer to own
Oli6 outperforming Bubs in China !!
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2989 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 52800 | 1 |
View Market Depth
| Last trade - 16.12pm 19/08/2024 (20 minute delay) ? |
| NUC (ASX) Chart |
Day chart unavailable